Quick Summary

Chinese Motherwort (Leonurus japonicus) is a traditional Chinese medicinal herb primarily used in gynecological conditions. Research evidence from clinical trials and systematic reviews suggests potential benefits in managing uterine bleeding, postpartum hemorrhage, and menstrual disorders. It also shows promise as an adjunct therapy in conditions such as multiple sclerosis. Preclinical studies indicate neuroprotective, anti-inflammatory, and cardioprotective potential. However, current clinical evidence is limited by methodological quality and low certainty, and further high-quality randomized controlled trials are needed.

What is it?

Chinese Motherwort is a perennial herb native to East Asia, known as Leonurus japonicus. It belongs to the Lamiaceae family and has been used in Traditional Chinese Medicine (TCM) for centuries. The plant’s aerial parts are commonly utilized for medicinal purposes.

Traditional Uses

In Traditional Chinese Medicine, Chinese Motherwort has been primarily used for gynecological issues including uterine bleeding, menstrual irregularities, and as a uterotonic to support postpartum recovery. It has also been employed to promote blood circulation and reduce stagnation.

Active Compounds

Phytochemical analyses have identified multiple active compounds in Chinese Motherwort, including alkaloids, flavonoids, and terpenoids. These constituents are thought to contribute to its pharmacological effects, such as anti-inflammatory and cardioprotective activities. However, specific compounds responsible for clinical effects are still under investigation.

Potential Benefits with Evidence Levels

  • Prevention of postpartum and postabortion hemorrhage: Moderate to low certainty evidence from systematic reviews and meta-analyses of randomized controlled trials suggests that motherwort injection combined with oxytocin may reduce blood loss and incidence of uterine hemorrhage after vaginal delivery, cesarean section, and induced abortion compared to oxytocin alone, with fewer adverse events reported (Xinyu et al., 2022; Yu et al., 2019; Li et al., 2022). However, the quality of evidence is limited by study design weaknesses.
  • Adjunctive therapy in multiple sclerosis: Low to moderate certainty evidence indicates that Chinese herbal medicine including motherwort, combined with conventional therapies, may improve disability scores, relapse rate, neurological signs, fatigue, and overall clinical effect for multiple sclerosis, showing a good safety profile. The methodological quality of included studies was suboptimal (Guan X et al., 2025).
  • Management of dysmenorrhea as adjunctive therapy: Low certainty evidence from systematic reviews suggests that Chinese herbal footbaths containing motherwort may improve pain intensity and symptoms associated with dysmenorrhea, with fewer adverse events. However, included studies were of low methodological quality (Tian et al., 2024).

Side Effects

Available clinical evidence indicates that motherwort injection is generally well tolerated, with fewer reported adverse events compared to standard treatments in postpartum and postabortion hemorrhage settings. No serious adverse effects have been reported in clinical trials. Animal and pharmacokinetic studies have not identified significant toxicity, although comprehensive toxicity data remain limited.

Drug Interactions

There is no direct clinical evidence on drug interactions specific to Chinese Motherwort. General caution is advised when combining motherwort with anticoagulant or antiplatelet medications due to a potential increased risk of bleeding. Herb-drug interactions involving aspirin and other Western medicines have been reported in Traditional Chinese Medicine contexts, but specific interactions with motherwort require further research.

Who Should Avoid It

Specific contraindications are not well established. Due to its uterotonic properties, caution is recommended for use during pregnancy because of potential effects on uterine contractility. Use during breastfeeding is not well studied, so avoidance or close monitoring is advised for pregnant or lactating women until further safety data are available.

Evidence Limitations

  • Most clinical studies have methodological flaws such as small sample sizes, lack of blinding, inadequate allocation concealment, and heterogeneity of interventions.
  • Systematic reviews generally report low to very low certainty of evidence due to risk of bias and imprecision.
  • Few studies provide long-term follow-up or comprehensive safety data.
  • Many results derive from combined herbal formulations rather than isolated motherwort, complicating attribution of effects.
  • Evidence from animal or in vitro studies cannot be directly extrapolated to humans without further clinical validation.

References

Last Reviewed

June 2024

Informational Disclaimer

This information is provided for educational purposes only and is not intended to substitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new herbal treatment, especially if you are pregnant, breastfeeding, taking medications, or have a medical condition.